REFERENCES

  1. McDonagh EM, Lau JL, Alvarellos ML, Altman RB, Klein TE. PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics. Pharmacogenetics and Genomics. 2015;25(7):363-376. doi:10.1097/fpc.0000000000000145
  2. Huang L, Sang CN, Desai MS. A Chronology for the Identification and Disclosure of Adverse Effects of Succinylcholine. Journal of Anesthesia History. 2019;5(3):65-84. doi:10.1016/j.janh.2018.07.003
  3. Dorkins HR. Suxamethonium-the development of a modern drug from 1906 to the present day. Medical History. 1982;26(2):145-168. doi:10.1017/s0025727300041132
  4. Stump, L. Neuromuscular Blockers 1.31. PowerPoint presented at University of Michigan Blackboard; April 2021; Flint, MI.
  5. Blobner M, Hunter JM. Another nail in the coffin of succinylcholine? British Journal of Anaesthesia. 2020;125(4):423-425. doi:10.1016/j.bja.2020.06.025
%d bloggers like this: